$COSM : Massive Operational Expansion & Robotic Scaling (Jan 20, 2026)

Cosmos Health Inc. (NASDAQ: COSM) dropped some significant fundamental news today regarding their Greek subsidiary, Cosmofarm. While the stock has been under pressure lately due to Nasdaq compliance hurdles, the operational side is showing serious momentum. 

🚀 The Big News: $40M Revenue Potential from Automation:

The company announced a major infrastructure expansion at Cosmofarm. Here are the highlights: 

• Robotic Expansion: They are currently executing a $1 million capital investment to expand their ROWA and A-frame robotic systems. This expansion is designed to support an incremental annual revenue potential of approximately $40 million. 

• Customer Growth: During 2025, Cosmofarm added nearly 100 new pharmacy customers, a 20% increase in their active base. 

• Improved Unit Economics: \* Annual revenue per customer: +12% 

• Profitability per customer: +14% 

• Logistics: Added three new delivery routes in the Attica region (Greece) to improve "last-mile" delivery and route density.

Insider Activity: CEO Greg Siokas has been putting his money where his mouth is. On January 14, he acquired 493,495 shares at $0.4458 (via a debt exchange), bringing his total ownership to over 7.7 million shares.

💡 Why This Matters

The market seems to be ignoring the fundamentals in favor of the delisting risk. However, with a market cap of only \~$18M and a trailing revenue of nearly $60M, the expansion into automation that could add another $40M in revenue makes this a classic "high-risk, high-reward" play.

The CEO is buying, the robots are coming, and the revenue is scaling—but the $1.00 price target remains the elephant in the room for the bulls.

What are your thoughts? Is the $40M revenue potential enough to squeeze this back over $1.00, or is the reverse split inevitable?

Disclaimer: Not financial advice. Do your own DD.